EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Impaired cathepsin D in retinal pigment epithelium cells mediates Stargardt disease pathogenesis

Eunice Sze Yin Ng iD, Jane Hu, Zhichun Jiang, Roxana A Radu iD

The FASEB Journal · 2024

DOI: 10.1096/fj.202400210rr ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, 2024. Verfasst von Eunice Sze Yin Ng und 3 weiteren Autor:innen. Beteiligte Einrichtung: UCLA Stein Eye Institute, University of California, Los Angeles, California, USA. Hauptthemen laut MEDLINE: Cathepsin D, Retinal Pigment Epithelium, Stargardt Disease, Lysosomes. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NEI NIH HHS, Research to Prevent Blindness (RPB), UC | UCLA | Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, University of California Los Angeles (Broad Stem Cell Research Center).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recessive Stargardt disease (STGD1) is an inherited juvenile maculopathy caused by mutations in the ABCA4 gene, for which there is no suitable treatment. Loss of functional ABCA4 in the retinal pigment epithelium (RPE) alone, without contribution from photoreceptor cells, was shown to induce STGD1 pathology. Here, we identified cathepsin D (CatD), the primary RPE lysosomal protease, as a key molecular player contributing to endo‐lysosomal dysfunction in STGD1 using a newly developed “disease‐in‐a‐dish” RPE model from confirmed STGD1 patients. Induced pluripotent stem cell (iPSC)‐derived RPE originating from three STGD1 patients exhibited elevated lysosomal pH, as previously reported in Abca4 −/− mice. CatD protein maturation and activity were impaired in RPE from STGD1 patients and Abca4 −/− mice. Consequently, STGD1 RPE cells have reduced photoreceptor outer segment degradation and abnormal accumulation of α‐synuclein, the natural substrate of CatD. Furthermore, dysfunctional ABCA4 in STGD1 RPE cells results in intracellular accumulation of autofluorescent material and phosphatidylethanolamine (PE). The altered distribution of PE associated with the internal membranes of STGD1 RPE cells presumably compromises LC3‐associated phagocytosis, contributing to delayed endo‐lysosomal degradation activity. Drug‐mediated re‐acidification of lysosomes in the RPE of STGD1 restores CatD functional activity and reduces the accumulation of immature CatD protein loads. This preclinical study validates the contribution of CatD deficiencies to STGD1 pathology and provides evidence for an efficacious therapeutic approach targeting RPE cells. Our findings support a cell‐autonomous RPE‐driven pathology, informing future research aimed at targeting RPE cells to treat ABCA4‐mediated retinopathies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cathepsin DRetinal Pigment EpitheliumStargardt DiseaseLysosomesATP-Binding Cassette TransportersAnimalsHumansMiceInduced Pluripotent Stem CellsMice, KnockoutMacular Degeneration

Stichwörter der Autor:innen

cathepsin Dendo‐lysosomephagocytosisphosphatidylethanolaminerecessive Stargardt diseaseretinal pigment epithelium

Substanzen

Cathepsin DATP-Binding Cassette TransportersAbca4 protein, mouseABCA4 protein, humanCTSD protein, human

Autor:innen und Institutionen

  • UCLA Stein Eye Institute, University of California, Los Angeles, California, USA.
  • Department of Ophthalmology, David Geffen School of Medicine, University of California, Los Angeles, California, USA.
  • Molecular, Cellular, and Integrative Physiology Interdepartmental Program, University of California, Los Angeles, California, USA.

ORCID-Profile: Eunice Sze Yin Ng, Roxana A Radu

Förderung

  • NEI NIH HHS
  • Research to Prevent Blindness (RPB)
  • UC | UCLA | Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, University of California Los Angeles (Broad Stem Cell Research Center)
  • HHS | NIH | National Eye Institute (NEI)
  • National Eye Institute
  • Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, University of California Los Angeles

Zitieren

APA

Ng, E. S. Y., Hu, J., Jiang, Z., & Radu, R. A. (2024). Impaired cathepsin D in retinal pigment epithelium cells mediates Stargardt disease pathogenesis. The FASEB Journal. https://doi.org/10.1096/fj.202400210rr

Vancouver

Ng ESY, Hu J, Jiang Z, Radu RA. Impaired cathepsin D in retinal pigment epithelium cells mediates Stargardt disease pathogenesis. The FASEB Journal. 2024. doi:10.1096/fj.202400210rr

BibTeX
@article{Ng2024,
  author = {Ng, Eunice Sze Yin and Hu, Jane and Jiang, Zhichun and Radu, Roxana A},
  title = {Impaired cathepsin D in retinal pigment epithelium cells mediates Stargardt disease pathogenesis},
  journal = {The FASEB Journal},
  year = {2024},
  doi = {10.1096/fj.202400210rr}
}
Kostenlos starten →